The Search for New Anti-Cancer Drugs

Dr. Claude Labrie (2001, 2002 and 2005 Research Grants)

Cancer cells are good at surviving, partially because of their ability to adapt to stress. Dr. Labrie’s lab has shown that the protein AIbZIP, which is found in high numbers in prostate cancer cells, helps cancer cells adapt to stress. He and his team have created peptides that can prevent AIbZIP from doing its job – which could ultimately cause the death of the cells. He is now testing the ability of these peptides to infiltrate cancer cells and cause cancer cell death. The long term goal of this research is to turn these cancer cell killing peptides into new anticancer drugs.

Help us take the first steps toward prevention. Donate Now


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More


Click here for news archive